Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations.

Ther Clin Risk Manag · 2022 · PMC8977472 · PMID 35386181

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep = 0.12not close (p > 0.1)

Rates of symptomatic hypotension were numerically higher with vericiguat (9.1%) compared to placebo (7.9%), although this did not reach statistical significance (p = 0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.